Silver Book Fact

Antihypertensive therapy has been associated in clinical trials with a 1/3 reduction in stroke incidence, a 1/4 reduction in myocardical infarctions and a more than 1/2 reduction in heart failure.

Chobanian, Aram, George Bakris, Henry Black, William Cushman, Lee Green, Joseph Izzo, Daniel Jones, Barry Materson, Suzanne Oparil, Jackson Wright, and Edward Roccella. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Hypertension. 2003; 42(6): 1206-52. https://jamanetwork.com/journals/jama/article-abstract/196589?redirect=true

Reference

Title
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure
Publication
Hypertension
Publication Date
2003
Authors
Chobanian, Aram, George Bakris, Henry Black, William Cushman, Lee Green, Joseph Izzo, Daniel Jones, Barry Materson, Suzanne Oparil, Jackson Wright, and Edward Roccella
Volume & Issue
Volume 42, Issue 6
Pages
1206-52
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Direct thrombin inhibitor reduced relative risk of venous thromboembolism
    An investigational direct thrombin inhibitor reduced relative risk of venous thromboembolism after total hip replacement surgery by 65.7%—compared to a currently available treatment.  
  • In 2005, approximately 469,000 coronary artery bypass procedures were performed on 261,000 patients in the U.S.  
  • In 2010, ~67,500 SAVRs were performed in the U.S.
     
  • About 1/2 of the decrease in recent deaths in cardiovascular disease can be attributed to medical treatment.  
  • Between 1981 and 2004, death rates for heart disease and stroke declined by about 44%.